financetom
Business
financetom
/
Business
/
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test
Mar 7, 2024 1:17 PM

03:58 PM EST, 03/07/2024 (MT Newswires) -- Co-Diagnostics ( CODX ) said Thursday that its manufacturing and sales joint venture in India, CoSara Diagnostics, received clearance from the Central Drugs Standard Control Organization to manufacture and sell the influenza multiplex test kit Saraplex.

The Indian regulator approved the sale of the test to clinical laboratories for the detection and differentiation of Influenza A and Influenza B, according to the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Seadrill Posts Lower Q1 Earnings, Higher Operating Revenue; Guidance Reaffirmed
Seadrill Posts Lower Q1 Earnings, Higher Operating Revenue; Guidance Reaffirmed
May 14, 2024
04:53 PM EDT, 05/14/2024 (MT Newswires) -- Seadrill ( SDRL ) late Tuesday reported Q1 earnings of $0.81 per diluted share, down from $0.83 a year earlier. Analysts polled by Capital IQ expected $0.67. Operating revenue for the quarter ended March 31 was $367 million, up from $266 million a year earlier. Analysts polled by Capital IQ expected $371.5 million....
Salesforce Insider Sold Shares Worth $4,152,578, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $4,152,578, According to a Recent SEC Filing
May 14, 2024
04:52 PM EDT, 05/14/2024 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on May 13, 2024, sold 15,000 shares in Salesforce ( CRM ) for $4,152,578. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,587,327 shares of the company, with 12,587,327 shares held directly and 10,000,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224015273/xslF345X03/form4.xml Price:...
Arcutis Biotherapeutics Q1 Loss Narrows, Revenue Increases; Shares Jump
Arcutis Biotherapeutics Q1 Loss Narrows, Revenue Increases; Shares Jump
May 14, 2024
04:53 PM EDT, 05/14/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) reported a Q1 loss Tuesday of $0.32 per diluted share, compared with a loss of $1.31 a year earlier. Analysts polled by Capital IQ expected a loss of $0.73. Revenue for the quarter that ended March 31 was $49.6 million, up from $2.8 million a year earlier. Analysts...
Plexus Insider Sold Shares Worth $348,131, According to a Recent SEC Filing
Plexus Insider Sold Shares Worth $348,131, According to a Recent SEC Filing
May 14, 2024
04:52 PM EDT, 05/14/2024 (MT Newswires) -- Todd P. Kelsey, Director, CEO, on May 10, 2024, sold 3,224 shares in Plexus (PLXS) for $348,131. Following the Form 4 filing with the SEC, Kelsey has control over a total of 114,401 shares of the company, with 104,338 shares held directly and 10,063 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/785786/000162828024023263/xslF345X03/wk-form4_1715719577.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved